Thanks to prof Pawlik for this insightful overview of the gall bladder cancer. His expertise in HB surgery is apparent all through his lecture. His statement as Biology is the core issue as regards prognosis is probably the essence of his talk.
Is it possible that at some stage molecular profiling may differentiate between the high risk patients with highest risk of recurrence and the low risk group ?
Thanks to prof Pawlik for this insightful overview of the gall bladder cancer. His expertise in HB surgery is apparent all through his lecture. His statement as Biology is the core issue as regards prognosis is probably the essence of his talk.
Dr Nagino is perhaps the only one with a series of hilar cholangio-ca wherein hepatectomy was done with PD though with a modest survival.
Is it possible that at some stage molecular profiling may differentiate between the high risk patients with highest risk of recurrence and the low risk group ?